Actualités

Ustekinumab may be more effective than anti-tumor necrosis factor (anti-TNF) therapies in achieving clinical remission among patients with Crohn-like disease of the pouch (CLDP), according to study ...
The FDA has accepted for review the sNDA for deucravacitinib for the treatment of adults with active psoriatic arthritis.
There was an increase in use of neuraxial anesthesia and peripheral nerve block analgesia rather than general anesthesia for hip fracture procedures.
Associations between neighborhood characteristics (e.g. air pollution and neighborhood socioeconomic status) and mental health outcomes varied by age.
The Trump administration’s immigration policies are having negative effects on health care, impacting patients and health ...
From 2016 to 2022, 5.3% of all US emergency department visits were related to low back pain, with opioid administration and prescription decreasing during this same time period.
There was an overall decrease in influenza vaccine uptake among US adults from 2020 to 2024, according to a study published online.
A new IVF technique helped 8 babies in the UK avoid serious inherited diseases, and scientists are calling it a breakthrough.
Ustekinumab is more efficacious than vedolizumab or anti-TNFs as second- or third-line biologic therapy for perianal Crohn disease.
Infliximab and efzofitimod may be effective in pulmonary sarcoidosis and tofacitinib and adalimumab in cutaneous sarcoidosis.
Hydroxychloroquine exposure during the first trimester of pregnancy was associated with a lower risk for preeclampsia among women with SLE.
Osteoporosis treatment was associated with reduced hospitalization and mortality risks following fragility fracture after 80 years of age.